Clinical trial
Open access
Oct 2026
Steady-State Pharmacokinetic Drug–Drug Interaction Study of Zastaprazan, a Novel Potassium-Competitive Acid Blocker, and Atorvastatin in Healthy Participants
Although atorvastatin reduced zastaprazan Cmax,ss, total exposure was preserved, a pattern consistent with altered absorption kinetics without establishing a specific mechanism, and pharmacokinetic findings do not suggest a need for atorvastatin dose adjustment under the studied conditions.
A-Young Yang, Hongsock Kim, H. Yoo et al.
· Drug Design, Development and... · 0 citations